Menta Capital’s Alimera Sciences ALIM Stock Holding History

Menta Capital’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,647	Closed	-$199K	–	787
2015 Q1	$199K	Sell	2,647 -1,522	-37%	-$120K	0.03%	618
2014 Q4	$346K	Buy	+4,169	New	+$338K	0.05%	515

Other funds holding ALIM

Scale Management Foster City, California $359M AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Menta Capital's ALIM Position: Q2 2015 in Review

Menta Capital sold out of Alimera Sciences (ALIM) in Q2 2015, closing a stake of 2,647 shares — an estimated $199K sold.

Menta Capital first reported a position in ALIM in Q4 2014 and held it in 2 quarters. The position peaked at $346K in Q4 2014. 64 funds tracked by Wall St. Rank hold ALIM as of Q2 2015.

Menta Capital reported no remaining Alimera Sciences position as of Q2 2015 after selling out during the quarter.
Menta Capital sold 2,647 Alimera Sciences shares in Q2 2015, an estimated $199K.
Menta Capital first reported a position in Alimera Sciences in Q4 2014 and held it in 2 quarters.
Menta Capital's Alimera Sciences position peaked at $346K in Q4 2014.
64 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2015.

Based on Menta Capital's 13F filing for Q2 2015, filed 11 Aug 2015.